Cancer resources for healthcare providers
Approximately 5-10% of all cancer is due to hereditary cancer syndromes. More cancers are likely influenced by genetic factors associated with moderate risk. Being able to identify individuals at increased cancer risk through family history and, in some cases, genetic testing, can influence management and outcomes through increasing screening and/or risk-reducing interventions. The resources below provide opportunities to learn about hereditary cancer syndromes, identify individuals at increased risk, interpret genetic testing results, apply genetic information to management, collaborate with genetics professionals, and communicate with patients.
Hereditary Breast and Ovarian Cancer Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of hereditary breast and ovarian cancer (HBOC) syndrome.
Lynch Syndrome Factsheet. Describes the clinical features, diagnosis, testing and genetics of Lynch syndrome (hereditary nonpolyposis colorectal cancer).
MUTYH-Associated Adenomatous Polyposis Factsheet. Describes the clinical features, diagnosis, testing and genetics of MUTYH-associated polyposis (MAP).
Accessing Genetic Services Tool. Lists tools and websites to help find genetics professionals and provides patient talking points about referring to genetics.
Breast Cancer Risk and Screening Guidelines Factsheet. Summarizes screening guidelines for patients at average, increased, and high genetic risk for breast cancer.
Cancer Risk Assessment Tool. Helps identify red flags and stratify cancer risk based on family history.
Cancer Screening Factsheet. Summarizes professional society guidance about screening for individuals at average, increased, and high risk for breast, prostate, and colorectal cancer.
Communicating Risk Factsheet. Outlines key points to consider when communicating risk to patients.
Components of a Cancer Genetic Counseling Session Factsheet. Discusses the core components of a cancer genetic counseling session.
Family History Collection Tips & Tools. Provides tips, resources, and tools for family history collection in clinical practice.
Genetic Testing Methods eBook. Provides information about different genetic testing methods currently used in testing for hereditary cancer syndromes (enhanced e-book available for download).
Inheritance Patterns Factsheet. Outlines common inheritance patterns of conditions with an underlying genetic component.
Pedigree Tool. A template to record a pedigree with standard pedigree nomenclature.
Pretest Counseling Key Points Factsheet. Outlines key points to address during pretest counseling.
Targeted Colorectal and Polyp Family History Tool. Lists key questions and guidance for collecting a family history targeted toward colorectal cancer.
Genomic Technologies for Oncologists eBook. Provides an overview of genomic technologies used in cancer research and clinical care (enhanced e-book available for download).
Hereditary Breast Cancer Patient and Family Resources. Provides patient resources for understanding genetic services and breast cancer genetics.
Free, self-directed programs for continuing education credit.
Learn how to identify, evaluate, and manage patients at increased risk of HBOC.
Access CME Module
Learn how to identify important test characteristics, compare and contrast offerings from different labs, find actionable information on the test report, and interpret results in the context of the individual patient.
Access CME Module | Access CNE Module
The Jackson Laboratory (JAX) has received $2.5 million from The Mark Foundation for Cancer Research to study in mice the influence of host...
Jackson Laboratory (JAX) Assistant Professor Sheng Li, Ph.D., was chosen as a 2020 NextGen Star by the American Association for Cancer...
The results of a new PDXNet consortium study provide a key validation toward translating xenograft findings into clinical...
Jackson Laboratory professor Dr. Roel Verhaak performed a study of cancer in dogs, looking for symptoms and cause of dog...
Helping clinicians take better family histories improves patient cancer risk assessments.
Splicing factors, comparable to gene editors in our DNA, could hold the key to treating the worst type of breast cancer.
The National Cancer Institute has awarded Jackson Laboratory cancer researcher Gary Ren a five-year grant totaling...
RNA splicing and cancer
The Jackson Laboratory provides the most widely published and cutting-edge models for oncology research and offers a comprehensive suite of...
Cutting Edge Bioinformatics for Preclinical Oncology. Dig deeper to understand tumor response or resistance to your...
Online Resources for Cancer Research
There are hundreds of JAX® Mice strains available for cancer research and drug efficacy testing. The table below summarizes...
Patient-derived tumor xenografts in humanized NSG™ and NSG™-SGM3 mice
The JAX ActionSeq™ test is a targeted panel of 212 cancer related genes analyzed using next-generation sequencing. The panel assesses all...
Cutting edge sequencing for preclinical oncology.
Every patient is unique. So is every patient’s tumor. This one pager explains how advances in high-throughput molecular diagnostics now...